Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Decade in review—polycystic kidney disease

Slowing progression of autosomal dominant polycystic kidney disease

Autosomal dominant polycystic kidney disease is a challenging disorder to diagnose and treat effectively. Promising research over the past decade has, however, provided novel interventions, modifications to clinical practice and new areas to investigate with the aim of identifying approaches to slow disease progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Pathogenic role of the renin–angiotensin–aldosterone system in ADPKD.

References

  1. Lantinga-van Leeuwen, I. S. et al. Lowering of Pkd1 is sufficient to cause polycystic kidney disease. Hum. Mol. Genet. 13, 3069–3077 (2004).

    Article  CAS  PubMed  Google Scholar 

  2. Cadnapaphornchai, M. A. et al. Prospective change in renal volume and function in children with ADPKD. Clin. J. Am. Soc. Nephrol. 4, 820–829 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Gile, R. D. et al. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat. Am. J. Kidney Dis. 26, 501–507 (1995).

    Article  CAS  PubMed  Google Scholar 

  4. Cadnapaphornchai, M. et al. Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 9, 889–896 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Schrier, R. W. et al. Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: Results of a seven-year prospective randomized study. J. Am. Soc. Nephrol. 13, 1733–1739 (2002).

    Article  PubMed  Google Scholar 

  6. Cadnapaphornchai, M. et al. Increased left ventricular mass in children with autosomal dominant polycystic kidney disease. Kidney Int. 74, 1192–1196 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Schrier, R. W. et al. Blood pressure in early autosomal dominant polycystic kidney disease. N. Engl. J. Med. 371, 2255–2266 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Schrier, R. W. et al. Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 22, 2361–2375 (2013).

    Google Scholar 

  9. Torres, V. E. et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 367, 2407–2418 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kurbegovic, A. & Trudel, M. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain. Hum. Mol. Genet. 22, 2361–2375 (2013).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert W. Schrier.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schrier, R. Slowing progression of autosomal dominant polycystic kidney disease. Nat Rev Nephrol 11, 638–639 (2015). https://doi.org/10.1038/nrneph.2015.164

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2015.164

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing